Dissemination and growth of cancer cells in metastatic sites

Ann F Chambers1, Alan C Groom, Ian C MacDonald

  • 1London Regional Cancer Centre, London, Ontario N6A 4L6, Canada. ann.chambers@lrcc.on.ca

Nature Reviews. Cancer
|August 3, 2002
PubMed

Insights

Metastases cause most cancer deaths, necessitating better treatments. Targeting the growth of secondary tumors offers a promising therapeutic strategy to improve patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Metastases, the spread of cancer from the primary site, are the leading cause of cancer-related mortality.
  • Current therapeutic strategies often focus on primary tumor control, with less emphasis on managing established metastatic disease.

Purpose of the Study:

  • To highlight the critical role of metastases in cancer-induced mortality.
  • To explore the biological and mechanical factors governing cancer cell dissemination and secondary tumor formation.
  • To underscore the therapeutic potential of inhibiting metastatic growth in secondary sites.

Main Methods:

  • Review and synthesis of existing research on cancer cell metastasis.
  • Analysis of factors influencing cancer cell transport via blood flow and mechanical forces.
  • Examination of molecular interactions critical for secondary tumor establishment and growth.

Main Results:

  • Cancer cell delivery to organs is influenced by hemodynamic and mechanical factors.
  • Successful metastasis outgrowth depends on specific molecular interactions between cancer cells and the secondary organ microenvironment.
  • Inhibiting metastatic growth presents a viable therapeutic avenue.

Conclusions:

  • Effective cancer treatment must address metastatic disease to reduce mortality.
  • Understanding the mechanisms of metastasis can lead to novel therapeutic targets.
  • Inhibiting the growth of secondary tumors is a promising strategy for improving cancer patient survival.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...